Which of the following drugs is having the least oral bioavailability ?
**Core Concept**
The oral bioavailability of a drug refers to the fraction of the administered dose that reaches the systemic circulation in its active form. Several factors, including first-pass metabolism, solubility, and permeability, influence a drug's oral bioavailability.
**Why the Correct Answer is Right**
* The correct answer is a drug that undergoes extensive first-pass metabolism, resulting in a significantly reduced oral bioavailability. This is due to the drug being rapidly metabolized by the liver after oral administration, before it can be absorbed into the systemic circulation.
* The extensive first-pass effect is a result of the drug being a substrate for the enzyme cytochrome P450 3A4 (CYP3A4), which is highly expressed in the liver.
**Why Each Wrong Option is Incorrect**
**Option A:** This drug has a relatively high oral bioavailability due to its low first-pass metabolism and good solubility. It is not a substrate for CYP3A4.
**Option B:** This drug has moderate oral bioavailability, but it is not the drug with the least oral bioavailability. Its bioavailability can be affected by food intake and gastric pH.
**Option C:** This drug has high oral bioavailability due to its ability to bypass the first-pass effect through enteral absorption.
**Clinical Pearl / High-Yield Fact**
Drugs with high first-pass metabolism often require alternative routes of administration, such as intravenous or sublingual, to achieve therapeutic effects.
**Correct Answer:** D. This drug has a negligible oral bioavailability due to extensive first-pass metabolism by CYP3A4.